金城医药(300233.SZ)实控人赵叶青收到行政处罚决定书

Core Viewpoint - The announcement reveals that the actual controller of Jincheng Pharmaceutical, Zhao Yeqing, along with two others, has been penalized for stock manipulation activities between August 18, 2017, and February 10, 2020 [1] Summary by Relevant Sections - Regulatory Action: The China Securities Regulatory Commission (CSRC) issued an administrative penalty decision against Zhao Yeqing, Wang Zhen, and Liu Feng for manipulating Jincheng Pharmaceutical's stock [1] - Penalties Imposed: A total fine of 3 million yuan was imposed, with Zhao Yeqing responsible for 1.5 million yuan, Wang Zhen for 1.2 million yuan, and Liu Feng for 300,000 yuan [1] - Market Ban: Zhao Yeqing has been banned from the market for 4 years, while Wang Zhen and Liu Feng have been banned for 3 years and 2 years, respectively [1]